BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33392783)

  • 1. Streptococcus dysgalactiae subsp. equisimilis from invasive and non-invasive infections in Spain: combining epidemiology, molecular characterization, and genetic diversity.
    Rojo-Bezares B; Toca L; Azcona-Gutiérrez JM; Ortega-Unanue N; Toledano P; Sáenz Y
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):1013-1021. PubMed ID: 33392783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of emm types and antimicrobial susceptibility of Streptococcus dysgalactiae subsp. equisimilis in Austria.
    Leitner E; Zollner-Schwetz I; Zarfel G; Masoud-Landgraf L; Gehrer M; Wagner-Eibel U; Grisold AJ; Feierl G
    Int J Med Microbiol; 2015 Dec; 305(8):918-24. PubMed ID: 26507866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of invasive Streptococcus dysgalactiae subsp. equisimilis. Multicenter study: Argentina 2011-2012.
    Traverso F; Blanco A; Villalón P; Beratz N; Sáez Nieto JA; Lopardo H;
    Rev Argent Microbiol; 2016; 48(4):279-289. PubMed ID: 28341023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization and antibiotic resistance of clinical Streptococcus dysgalactiae subsp. equisimilis in Beijing, China.
    Lu B; Fang Y; Huang L; Diao B; Du X; Kan B; Cui Y; Zhu F; Li D; Wang D
    Infect Genet Evol; 2016 Jun; 40():119-125. PubMed ID: 26925701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic diversity and virulence properties of Streptococcus dysgalactiae subsp. equisimilis from different sources.
    Gherardi G; Imperi M; Palmieri C; Magi G; Facinelli B; Baldassarri L; Pataracchia M; Creti R
    J Med Microbiol; 2014 Jan; 63(Pt 1):90-98. PubMed ID: 24149625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility and genetic relationships among Streptococcus dysgalactiae subsp. equisimilis isolates in Rio de Janeiro.
    de Souza JP; Santos AR; de Paula GR; Barros RR
    Infect Dis (Lond); 2016 Sep; 48(9):676-81. PubMed ID: 27301015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of virulence genes to clinical manifestations and outcome in patients with Streptococcus dysgalactiae subspecies equisimilis bacteremia.
    Tsai CT; Chi CY; Ho CM; Lin PC; Chou CH; Wang JH; Wang JH; Lin HC; Tien N; Lin KH; Ho MW; Lu JJ
    J Microbiol Immunol Infect; 2014 Dec; 47(6):462-8. PubMed ID: 24210866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of virulence factors and association with emm polymorphism or isolation site among beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis.
    Lo HH; Cheng WS
    APMIS; 2015 Jan; 123(1):45-52. PubMed ID: 25244428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Diversity in Streptococcus dysgalactiae subsp. equisimilis Isolates from Patients with Invasive and Noninvasive Infections in a Japanese University Hospital (2014-2015).
    Fujita T; Horiuchi A; Ogawa M; Yoshida H; Hirose Y; Nagano N; Takahashi T
    Jpn J Infect Dis; 2017 Jan; 70(1):100-104. PubMed ID: 27000456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular emm genotyping and antibiotic susceptibility of Streptococcus dysgalactiae subsp. equisimilis isolated from invasive and non-invasive infections.
    Sunaoshi K; Murayama SY; Adachi K; Yagoshi M; Okuzumi K; Chiba N; Morozumi M; Ubukata K
    J Med Microbiol; 2010 Jan; 59(Pt 1):82-88. PubMed ID: 19745030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization and antibiotic resistance of Streptococcus dysgalactiae subspecies equisimilis isolated from patients with streptococcal toxic shock syndrome.
    Ikebe T; Okuno R; Sasaki M; Kanda Y; Otsuka H; Kawahara R; Ohya H; Suzuki M; Uchida K; Nihonmatsu H; Ohnishi M;
    J Infect Chemother; 2018 Feb; 24(2):117-122. PubMed ID: 29107650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Characterization of Invasive Streptococcus dysgalactiae subsp. equisimilis, Japan.
    Wajima T; Morozumi M; Hanada S; Sunaoshi K; Chiba N; Iwata S; Ubukata K
    Emerg Infect Dis; 2016 Feb; 22(2):247-54. PubMed ID: 26760778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular subtyping and antimicrobial susceptibility of
    Oh SI; Kim JW; Kim J; So B; Kim B; Kim HY
    J Vet Sci; 2020 Jul; 21(4):e57. PubMed ID: 32735095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group C Streptococcus dysgalactiae subsp. equisimilis in south-east Brazil: genetic diversity, resistance profile and the first report of human and equine isolates belonging to the same multilocus sequence typing lineage.
    Silva LG; Genteluci GL; Corrêa de Mattos M; Glatthardt T; Sá Figueiredo AM; Ferreira-Carvalho BT
    J Med Microbiol; 2015 May; 64(Pt 5):551-558. PubMed ID: 25752850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Epidemiological Features and Antibiotic Susceptibility Patterns of Streptococcus dysgalactiae subsp. equisimilis Isolates from Korea and Japan.
    Kim S; Byun JH; Park H; Lee J; Lee HS; Yoshida H; Shibayama A; Fujita T; Tsuyuki Y; Takahashi T
    Ann Lab Med; 2018 May; 38(3):212-219. PubMed ID: 29401555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibilities, streptococcal pyrogenic exotoxin gene profiles among clinical isolates of group C or G Streptococcus dysgalactiae subsp. equisimilis & of group G S. anginosus group at a tertiary care centre.
    Behera B; Mathur P; Bhardwaj N; Jain N; Misra MC; Kapil A; Singh S
    Indian J Med Res; 2014 Mar; 139(3):438-45. PubMed ID: 24820839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of a Streptococcus dysgalactiae subspecies equisimilis stG62647-lineage associated with severe clinical manifestations.
    Oppegaard O; Mylvaganam H; Skrede S; Lindemann PC; Kittang BR
    Sci Rep; 2017 Aug; 7(1):7589. PubMed ID: 28790435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization and antibiotic resistance of group G streptococci in Israel: comparison of invasive, non-invasive and carriage isolates.
    Halperin T; Levine H; Korenman Z; Burstein S; Amber R; Sela T; Valinsky L
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1649-54. PubMed ID: 27325440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Complement-Mediated Cell Lysis-like Gene (sicG) in Streptococcus dysgalactiae subsp. equisimilis Isolates From Japan (2014-2016).
    Takahashi T; Fujita T; Shibayama A; Tsuyuki Y; Yoshida H
    Ann Lab Med; 2017 Jul; 37(4):297-304. PubMed ID: 28445008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States.
    Ahmad Y; Gertz RE; Li Z; Sakota V; Broyles LN; Van Beneden C; Facklam R; Shewmaker PL; Reingold A; Farley MM; Beall BW
    J Clin Microbiol; 2009 Jul; 47(7):2046-54. PubMed ID: 19386831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.